In the present study, IGFBP-3 expression was examined in EGFR mutant lung cancer cells with acquired resistance to EGFR-TKIs, and the value of serum IGFBP-3 level was evaluated as a marker of resistance. The gene discussed is IGFBP3; the disease is lung carcinoma.